PIPE-307 Dose A
PIPE 307-201
Phase 2 small_molecule completed
Quick answer
PIPE-307 Dose A for Relapsing Remitting Multiple Sclerosis is a Phase 2 program (small_molecule) at Contineum Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Contineum Therapeutics
- Indication
- Relapsing Remitting Multiple Sclerosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed